Tag: Advanced Recurrent Ovarian Cancer Market
-
Advanced Recurrent Ovarian Cancer Market, Epidemiology, Pipeline, Drugs, Companies and Competitive Analysis by DelveInsight
Ovarian cancer is the most lethal gynaecological malignancy that presents at an advanced stage in 75% of patients. Ovarian cancer is predominantly a disease of older, postmenopausal women with the majority (>80%) of cases being diagnosed in women over 50 years. The exact cause of ovarian cancer remains unknown, but many associated risk factors have…